期刊文献+

酪氨酸激酶抑制剂STI571对K562细胞生长和凋亡的影响 被引量:1

Effect of tyrosine protein kinase inhibitor STI571 on growth and apoptosis of K562 cells
下载PDF
导出
摘要 目的:探讨酪氨酸激酶(TPK)抑制剂STI571对K562细胞生长和凋亡的影响。方法:取对数生长期K562细胞,分4组培养。Ⅰ组不加任何药物,Ⅱ组、Ⅲ组、Ⅳ组分别加0.5μmol/L、1μmol/L和2μmol/L的STI571,继续培养5d。每d行细胞计数,台盼蓝拒染法检测细胞活力,连测5d。培养36h时,取细胞,双缩脲法检测细胞蛋白含量,采取蛋白免疫印迹法进行Procaspase-3及Bcl-xL检测。结果:Ⅱ组、Ⅲ组细胞数低于同一时间段Ⅰ组细胞数(P<0.05),但高于Ⅳ组细胞数(P<0.05)。与Ⅰ组比较,Ⅱ组、Ⅲ组和Ⅳ组Procaspase-3和Bcl-xL蛋白表达降低(P<0.01);与Ⅱ组和Ⅲ组比,Ⅳ组2者表达量更低(P<0.01)。结论:STI571通过下调Bcl-xL,激活Procaspase-3,诱导K562细胞凋亡,从而抑制K562细胞的生长。 Aim. To explore the effect of tyrosine protein kinase inhibitor STI571 on growth and apoptosis of K562 cells. Methods:K562 cell line were divided into 4 groups, Group Ⅰ was the control, Group Ⅱ ,Group Ⅲ ,Groupiv were cultured with 0.5 μmol/L, 1 μmol/L, and 2 μmol/L STI571, respectively, for 5 days. The numbers of cells were recorded every day, and the expression of Bcl-xL and Procaspase-3 of cells cultured for 36 h were studied by Western blot. Results: The numbers of Group Ⅱ , Group Ⅲ were higher than that of Group I , but lower than that of group IV ( P 〈 0.05 ). Compared with group Ⅰ , the expression of Procaspase-3 and Bcl-xL of group Ⅱ , group Ⅲ and group IV were lower(P 〈 0.01 ) , and the expression of group IV was lower than those of Group Ⅱ and Group Ⅲ ( P 〈 0.01 ). Conclusion : STI571 can suppress the expression of Bcl-xL and Procaspase-3, and inhibit the growth of K562 cell.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第2期245-247,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省教育厅自然科学基金资助项目2006310017
关键词 STI571 K562细胞株 BCL-XL Procaspase-3 STI571 K562 cell line Bcl-xL Procaspase-3
  • 相关文献

参考文献8

  • 1Faderl S,Talpaz M,Estrov Z,et al.The biology of chronic myeloid leukemia[J].N Engl J Med,1999,341(3):164
  • 2Mauro MJ,O'Mwyer M,Heinrich MC,et a1.STI571:a paradigm of new agents for cancer therapeutics[J].J Clin Oncol,2002,20(1):325
  • 3岳枫,马文丽,宋艳斌,石嵘,张宝,郑文岭.RNAi技术沉默K562细胞中c-myc基因的初步研究[J].第一军医大学学报,2005,25(6):647-650. 被引量:5
  • 4付春景,李金龙,黄幼田,申琦,郑智敏,宫亚欧.STI571及As_2O_3诱导K562细胞凋亡机制的研究[J].中国病理生理杂志,2004,20(10):1919-1920. 被引量:6
  • 5骆林胜,张日,朱子玲,常伟荣,肖溶.As_2O_3与STI571单用及联用对K562细胞bcr-abl磷酸化的影响[J].白血病.淋巴瘤,2005,14(2):76-79. 被引量:5
  • 6Kashige N,Carpino N,Kobayshi R.Tyrosine phosphorylation of P62dokby P210bcr/abl inhibits RasGAP activity[J].Proc Natl Acad Sci USA,2000,97(5):2 093
  • 7Battle TE,Frank DA.The role of STATs in apoptosis[J].Curr Mol Med,2002,2(4):381
  • 8de Groot RP,Raaijmakers JA,Lammers JW,et al.STAT5-dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells[J].Mol Cell Biol Res Commun,2000,3(5):299

二级参考文献23

  • 1戴木水,罗绍凯,戴丽君,洪文德,彭爱华.反义 bcr/abl 寡核苷酸诱导 K562 细胞凋亡的研究[J].中华血液学杂志,1997,18(5):264-265. 被引量:6
  • 2Deininger MWN, Vieira S, Mendiola R, et al. bcr-abl tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia[J]. Cancer Res, 2000, 60:2049 -2055.
  • 3O' Dwyer M E, Mauro M J, Druker B J. Recent advancements in the treatment of chronic myelogenous leukemia[J]. Annu Rev Med, 2002,53:369-381.
  • 4Porosnicu M, Nimmanapalli R, Nguyen D, et al. Co- treatment with As2O3 enhances selective cytotoxic effects of STI-571 against bcr-ablpositive acute leukemia cells[J]. Leukemia, 2001, 15:772-778.
  • 5La Rosee P, Johnson K, O'Dwyer M E, et al. In vitro studies of the combination of imatinib mesylate (Gleevec)> and arsenic trioxide (Trisenox) in chronic myelogenous leukemia[J]. Exp Hematol, 2002,30:729 -737.
  • 6Tracyg LUG. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products[J]. Science, 1990, 247(4946):1079-1081.
  • 7Machiko H, Enrique JA, Adalberto B. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cell by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-XL[J]. J Exp Med, 2000, 191(6)
  • 8Shen ZY, Shen J, Cai WJ, et al. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells[J]. Int J Mol Med, 2000, 5(2): 155-158.
  • 9Wilson H M Jr, Hyman MS, Janet SL, et al. Mechanisms of action of arsenic trioxide[J]. Cancer Res, 2002, 62: 3893-3903.
  • 10Monika W, Uta F, Wilhelm W, et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference(RNAi) [ J ]. Oncogene,2002, 21 (5): 5716-24.

共引文献13

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部